Structure elucidation and conformational study of V8
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 40 (5) , 1097-1104
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Losartan’s molecular basis of interaction with membranes and AT1 receptorChemistry and Physics of Lipids, 2003
- Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacyJournal of Pharmaceutical and Biomedical Analysis, 2003
- Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT1 antagonistJournal of Pharmaceutical and Biomedical Analysis, 2002
- Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of π*–π* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT1 non-peptide antagonistsBioorganic & Medicinal Chemistry, 2001
- An Effort To Understand the Molecular Basis of Hypertension through the Study of Conformational Analysis of Losartan and Sarmesin Using a Combination of Nuclear Magnetic Resonance Spectroscopy and Theoretical CalculationsJournal of Medicinal Chemistry, 1999
- Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive TherapyJournal of Medicinal Chemistry, 1996
- The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonistMedicinal Research Reviews, 1992
- Nonpeptide angiotensin II receptor antagonistsTrends in Pharmacological Sciences, 1991
- The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensivesJournal of Medicinal Chemistry, 1990
- The key role of residue 5 in angiotensin IIBiopolymers, 1983